![Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlled, open-label, phase 3b trial - The Lancet Neurology Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlled, open-label, phase 3b trial - The Lancet Neurology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/3d2f94a7-568b-4a6b-9bb3-282015885f03/gr1_lrg.jpg)
Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlled, open-label, phase 3b trial - The Lancet Neurology
![Human leukocyte antigen (HLA) class II peptide flanking residues tune the immunogenicity of a human tumor-derived epitope - Journal of Biological Chemistry Human leukocyte antigen (HLA) class II peptide flanking residues tune the immunogenicity of a human tumor-derived epitope - Journal of Biological Chemistry](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/97815d7d-7a21-4ba7-b1f3-34a955b6ca42/gr1.jpg)
Human leukocyte antigen (HLA) class II peptide flanking residues tune the immunogenicity of a human tumor-derived epitope - Journal of Biological Chemistry
![Monocytic Human Leukocyte Antigen DR Expression in Young Infants Undergoing Cardiopulmonary Bypass - The Annals of Thoracic Surgery Monocytic Human Leukocyte Antigen DR Expression in Young Infants Undergoing Cardiopulmonary Bypass - The Annals of Thoracic Surgery](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2398c74f-27b8-4426-a231-01d710b11c48/fx1_lrg.jpg)
Monocytic Human Leukocyte Antigen DR Expression in Young Infants Undergoing Cardiopulmonary Bypass - The Annals of Thoracic Surgery
![Permeability of the Endothelial Barrier: Identifying and Reconciling Controversies: Trends in Molecular Medicine Permeability of the Endothelial Barrier: Identifying and Reconciling Controversies: Trends in Molecular Medicine](https://www.cell.com/cms/attachment/4eb86afd-b6de-4f0b-a53b-ec52d541e444/gr1_lrg.jpg)
Permeability of the Endothelial Barrier: Identifying and Reconciling Controversies: Trends in Molecular Medicine
![JCM | Free Full-Text | Lymphopenia as a Predictor for Adverse Clinical Outcomes in Hospitalized Patients with COVID-19: A Single Center Retrospective Study of 4485 Cases | HTML JCM | Free Full-Text | Lymphopenia as a Predictor for Adverse Clinical Outcomes in Hospitalized Patients with COVID-19: A Single Center Retrospective Study of 4485 Cases | HTML](https://www.mdpi.com/jcm/jcm-11-00700/article_deploy/html/images/jcm-11-00700-g001.png)
JCM | Free Full-Text | Lymphopenia as a Predictor for Adverse Clinical Outcomes in Hospitalized Patients with COVID-19: A Single Center Retrospective Study of 4485 Cases | HTML
![Neutrophils in host defense: new insights from zebrafish - Harvie - 2015 - Journal of Leukocyte Biology - Wiley Online Library Neutrophils in host defense: new insights from zebrafish - Harvie - 2015 - Journal of Leukocyte Biology - Wiley Online Library](https://jlb.onlinelibrary.wiley.com/cms/asset/6452b604-f594-491d-a6ac-0183f5ef1555/jlb.2015.98.issue-4.cover.jpg?trick=1657170203804)
Neutrophils in host defense: new insights from zebrafish - Harvie - 2015 - Journal of Leukocyte Biology - Wiley Online Library
![Malat1 long noncoding RNA regulates inflammation and leukocyte differentiation in experimental autoimmune encephalomyelitis - Journal of Neuroimmunology Malat1 long noncoding RNA regulates inflammation and leukocyte differentiation in experimental autoimmune encephalomyelitis - Journal of Neuroimmunology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/95dd1378-9e9b-4a57-a87e-172b49ada905/ga1_lrg.jpg)
Malat1 long noncoding RNA regulates inflammation and leukocyte differentiation in experimental autoimmune encephalomyelitis - Journal of Neuroimmunology
![IJMS | Free Full-Text | Immune Function of Endothelial Cells: Evolutionary Aspects, Molecular Biology and Role in Atherogenesis | HTML IJMS | Free Full-Text | Immune Function of Endothelial Cells: Evolutionary Aspects, Molecular Biology and Role in Atherogenesis | HTML](https://www.mdpi.com/ijms/ijms-23-09770/article_deploy/html/images/ijms-23-09770-g001.png)